Special Interest Group Satellites (SIGs)

Member led Special Interest Group Satellites are programmed by members for members.  With the support of SLB, these sessions will add to the value of 2019 attendance and provide extended learning opportunities. Consider hosting your own SIG and contact us for availability. There is a $20 USD fee for attending the SIGs. Sign-up and secure your spot during the main registration process. Main conference registration is required to join for the SIGs. Review all 8 options below. There is one full day option, 3 morning sessions and 4 afternoon sessions.

November 15, 2019

9:00 am – 5:00 pm

Alcohol & Tissue-Specific Immunity (AIRIG)
Chairs:Elizabeth J. Kovacs, University of Colorado, Denver & Mashkoor A. Choudhry, Loyola University, Chicago

  • Majid Afshar, MD, MS, Loyola University Chicago, Blood and urine biomarkers for identifying alcohol misuse in trauma patients
  • Leon G. Coleman, Jr., MD, PhD, University of North Carolina, Chapel Hill, Neuroimmune Mechanisms of Alcoholic Neurodegeneration and Negative Affect
  • Rebecca McCullough, PhD, University of Colorado Denver, Targeting the resolution of inflammation with a novel cell-based therapy in Alcoholic Liver Disease.
  • Vasilis Vasiliou, PhD, Yale University, Biomarkers and Novel Pathways Involved in the Development of Alcoholic Liver Disease
  • H. Joe Wang, PhD, NIAAA, Funding and training opportunities

9:00 am – 12:00 pm

Immunomodulatory Cell Death

Chairs: Ben A. Croker, Boston Children’s Hospital, Harvard Medical School, Kristopher Sarosiek, Harvard T.H. Chan School of Public Health

  • Ben A. Croker, Boston Children’s Hospital, Harvard Medical School, Effector Functions of Neutrophil Necroptosis
  • Andrew Oberst, University of Washington, Necroptosis Minus Cell Death Equals Antiviral Immunity in the Brain
  •  Kristopher Sarosiek, Harvard T.H. Chan School of Public Health, Enhancing Anti-cancer Immune Responses by Modulating Tumor Cell Death
  • Kate Schroder, The University of Queensland, New Insights into Non-canonical Inflammasome Signaling and Functions in Host Defense
  • Eric Baehrecke, University of Massachusetts Medical School, Identification of Novel Regulators of Autophagy that Promote Cell Death


Progress in CRISPR-Cas Biology and Gene Editing
Chair: Min Wu, University of North Dakota

  • Zhiwei Huang, Harbin Institute of Technology, How the Unique Structures of CRISPR-Cas Facilitate the Gene Editing
  • Samira Kiani, Arizona State University, How Many Applications Can the CRISPR Biotechnology Bring?
  • Eugene Koonin, NIH, The Expanding CRISPR Universe
  • Ailong Ke, Cornell, Structure and Function for CRISPR-Cas Research: The Recent Highlights
  • Min Wu, University of North Dakota, Can We Find or Reinvent the Best CRISPR-Cas for Gene Editing?


Resolution of Inflammation
Chairs: Charles N Serhan and Stephania Libreros, Harvard Medical School and Brigham and Women’s Hospital

Sponsored by Corbus Pharmaceuticals

  • Charles N Serhan, Harvard Medical School and Brigham and Women’s Hospital, Novel Mediators of Inflammation Resolution and Tissue Regeneration
  • Matthew Spite, Harvard Medical School and Brigham and Women’s Hospital, Lipid Mediators at the Interface of Resolution of Inflammation and Tissue Repair
  • Barbara White, Corbus Pharmaceutics, Cannabinoid Agonist Activation of Pro-resolving Lipid Mediators in Humans
  • Gabrielle Fredman, Albany Medical College, Resolvin D1 Enhances Necroptotic Cell Clearance
  • Daniel Irimia, Harvard Medical School and Massachusetts General Hospital, Lipid Mediators of Neutrophil Swarming

1:00 pm – 4:00 pm

Immune Regulation, Autoimmunity and Infection
Chairs: Rachel Caspi, NIH, WanJun Chen, NIH

  • Philip Murphy, NIAID, NIH, Treatment and Cure Strategies for WHIM Syndrome Immunodeficiency
  • Munir Akkaya, NIAID, NIH, How TLR9 Signaling Shapes the Survival, Differentiation and the Metabolism of B Cells
  • Mate Tolnay, CDER, FDA, Human FCRL3 Binds Secretory IgA, an Essential Component of Mucosal Immunity, and Restrains Regulatory T Cell Activity
  • Daniela Verthelyi, FDA, Modeling Neurotropic Viruses in Immunocompetent Mice: What Have We Learned So Far
  • Rachel Caspi, NEI, NIH, Th17 Effector Regulation in Ocular Inflammatory Disease
  • Billur Akkaya, NIAID, NIH, Tregs Orchestrate Antigen Specific Suppression via Stripping Cognate Peptide-MHCII from the DC Surface
  • WanJun Chen, NIDCR, NIH, D-mannose Induces Regulatory T cells and Suppresses Autoimmunity and Inflammation


Advanced Imaging Approaches to Visualize Immune Cell Behavior
Chairs: Margarida Barroso, Albany Medical College, Sergio Catz, The Scripps Research Institute

Sponsored by the Histochemical Society

  • Sergio Catz, The Scripps Research Institute, Application of Total Internal Reflection Fluorescence and Super Resolution Microscopy to the Study of Neutrophil Function
  • Margarida Barroso, Albany Medical College, Fluorescence Lifetime and FRET Based Approaches to Visualize Immune Cell Function
  • Klaus Ley, La Jolla Institute for Immunology, Pushing the Limits of Superresolution: SuperSTORM
  • Mauricio Terebiznik, University of Toronto, Technical approaches to study phagosome formation and maturation: Use of filamentous particles
  • David Entenberg, Albert Einstein College of Medicine, Broadening the Reach of Intravital Imaging through Surgical Engineering


Impact of Aging on Tissue Resident Immune Cells
Chair: Rebecca Fuldner, NIA, NIH

  • David Koelle, University of Washington, Skin-resident T Cell Responses to VZV Infection and Vaccination
  • Susan Swain, University of Massachusetts Medical School, Tissue Resident Memory Cells and Aging
  • Deep Dixit, Yale University, Adipose Tissue Resident Leukocytes in Aging and Inflammation
  • Joanne Turner, Texas Biomedical Research Institute, Exploring the Impact of Inflammaging on Immune Function During M. tb Infection


Global Science: Focus on Advancements in Immunology Research
Chair: Luis Montaner, Wistar, JLB Editor-in-Chief

South Korea:

  • Byoung S. Kwon, Eutilex Co., AITR Mediates the Polarization of CD4 T cells to Th1, Th2 and Th17, and Converts Treg to Th1 and Eradicates Solid Tumors
  • Gap Ryol Lee, Sogang University, The Role of PTEN in Th17 Cell Differentiation


  • Bin Li, Shanghai JiaoTong University, FOXP3+Treg Functional Stability and their Clinical Applications
  • Xiaoyu Hu, Institute for Immunology, Tsinghua University, Amino Acid Metabolites Modulate Cytokine Responses and Reprogram Macrophage Polarization


  • Kensuke Miyake, The University of Tokyo, Mechanisms Controlling Innate Immune Responses to Nucleic Acids
  • Motonari Kondo, Toho University School of Medicine, SATB1, A Nuclear Protein Necessary for Establishment of Immune Tolerance

South Africa & Malawi:

  • Clive Gray, University of Cape Town, The Impact of HIV Infection on Treg Populations in the Placenta and Adverse Birth Outcomes
  • Henry C Mwandumba, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, The Impact of HIV Infection on Lung Immunity and Control of Mycobacterium tuberculosis Infection